Transcend Capital Advisors LLC Raises Stock Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Transcend Capital Advisors LLC boosted its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 52.5% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 48,204 shares of the exchange traded fund’s stock after buying an additional 16,605 shares during the period. Transcend Capital Advisors LLC owned 0.06% of SPDR S&P Biotech ETF worth $4,304,000 as of its most recent SEC filing.

A number of other institutional investors have also bought and sold shares of the business. EPG Wealth Management LLC grew its position in shares of SPDR S&P Biotech ETF by 152.7% during the third quarter. EPG Wealth Management LLC now owns 460 shares of the exchange traded fund’s stock valued at $34,000 after purchasing an additional 278 shares in the last quarter. Tennessee Valley Asset Management Partners purchased a new position in shares of SPDR S&P Biotech ETF during the fourth quarter valued at about $44,000. Wetzel Investment Advisors Inc. purchased a new position in shares of SPDR S&P Biotech ETF during the fourth quarter valued at about $45,000. Life Planning Partners Inc purchased a new position in shares of SPDR S&P Biotech ETF during the fourth quarter valued at about $64,000. Finally, Sheets Smith Wealth Management purchased a new position in shares of SPDR S&P Biotech ETF during the third quarter valued at about $55,000.

SPDR S&P Biotech ETF Price Performance

Shares of SPDR S&P Biotech ETF stock traded up $1.27 during trading on Friday, reaching $83.49. 10,452,779 shares of the stock traded hands, compared to its average volume of 11,723,970. The company has a market capitalization of $6.49 billion, a price-to-earnings ratio of 11.47 and a beta of 1.08. The business has a fifty day simple moving average of $92.69 and a two-hundred day simple moving average of $84.64. SPDR S&P Biotech ETF has a 52-week low of $63.80 and a 52-week high of $103.52.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.